Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7427-7435
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7427
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7427
Table 2 Liver fibrosis markers developed for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Liver fibrosis markers for NAFLD | Items | Cohort | AUROC for diagnosis | Ref. |
HAIR | Hypertension, ALT, insulin resistance | 105 | Stage 3-4: 0.90 | Dixon et al[47], 2001 |
BAAT score | BMI, Age, ALT, Triglycerides | 93 | Stage 2-4: 0.84 | Ratziu et al[48], 2000 |
NAFLD Fibrosis score | Age, BMI, Hyperglycemia, Platelet count, Albumin, AST/ALT ratio | 733 | Stage 3-4: 0.84 | Angulo et al[49], 2007 |
BAAD score | BMI, AST/ALT ratio, DM | 827 | Stage 3-4: 0.81 | Harrison et al[51], 2008 |
FibroMeter NAFLD | Glucose, AST, Platelet count, ALT, Ferritin, Body Weight, Age | 235 | Stage 2-4: 0.943 | Calès et al[52], 2009 |
NAFLD Diagnostic Panel | DM, Gender, BMI, Triglycerides, CK18 fragments (apoptotic and necrotic) | 79 | 1Stage 1-4: 0.81,2Stage 2-4: 0.80 | Younossi et al[54], 2011 |
NAFIC score | Ferritin, IRI, type IV collagen 7S | 619 | Stage 2-4: 0.834, Stage 3-4: 0.869 | Sumida et al[53], 2011 |
- Citation: Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(24): 7427-7435
- URL: https://www.wjgnet.com/1007-9327/full/v21/i24/7427.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i24.7427